PenderFund Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

PenderFund Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,580	Closed	-$514K	–	147
2023 Q4	$514K	Buy	+23,580	New	+$371K	0.17%	57

PenderFund Capital Management's ORTX Position: Q1 2024 in Review

PenderFund Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 23,580 shares — an estimated $514K sold.

PenderFund Capital Management first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $514K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

PenderFund Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
PenderFund Capital Management sold 23,580 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $514K.
PenderFund Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
PenderFund Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $514K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on PenderFund Capital Management's 13F filing for Q1 2024, filed 15 May 2024.